Many people attribute these symptoms to the GLP-1 medication itself when the real culprit is a correctable nutrient deficiency
However, ROS may have a cytotoxic effect to cancer cell if the ROS reaches a certain threshold level 56
Cardiovascular and Long-Term Health Benefits Beyond Blood Sugar The SUSTAIN-6 cardiovascular outcomes trial (2016) established that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) by 26 percent in people with type 2 diabetes and existing cardiovascular disease or risk factors
Wolf J, Seto T, Han J-Y, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, et al